MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-11-2023
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
181 M |
Market Cap[1] |
$ 468 M |
EBITDA (LTM) |
$ -102 M |
P/E (LTM) |
- |
P/S (LTM) |
6.19 |
EPS (LTM) |
-0.64 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Xtant Medical Holdings
XTNT
|
$ 0.55 | -2.31 % | $ 73.5 M | NYSE American | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Zimmer Biomet Holdings
ZBH
|
$ 88.57 | -0.65 % | $ 18 B | NYSE,SPB | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Alphatec Holdings
ATEC
|
$ 10.93 | -5.12 % | $ 1.64 B | Nasdaq Global Select Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Accuray Incorporated
ARAY
|
$ 0.4 | 4.21 % | $ 41.1 M | Nasdaq Global Select Market | USA |
 |
Insulet Corporation
PODD
|
$ 208.22 | -4.53 % | $ 14.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
CONMED Corporation
CNMD
|
$ 34.58 | -5.62 % | $ 1.07 B | NYSE,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.59 | -1.18 % | $ 32.1 M | Nasdaq Capital Market | USA |
 |
Aethlon Medical
AEMD
|
$ 2.15 | -5.29 % | $ 3.36 M | Nasdaq Capital Market | USA |
 |
Edwards Lifesciences Corporation
EW
|
$ 79.34 | -3.36 % | $ 46.4 B | NYSE,SPB | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 11.2 | -1.84 % | $ 1.51 B | Nasdaq Capital Market | USA |
 |
OrthoPediatrics Corp.
KIDS
|
$ 15.52 | -5.08 % | $ 364 M | Nasdaq Global Select Market,SPB | USA |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
Ra Medical Systems
RMED
|
- | 10.0 % | $ 610 K | NYSE American | USA |
 |
Myomo
MYO
|
$ 0.7 | 2.32 % | $ 29.3 M | NYSE American | USA |
 |
Penumbra
PEN
|
$ 335.1 | -0.39 % | $ 13 B | NYSE,SPB | USA |
 |
Inspire Medical Systems
INSP
|
$ 50.13 | -0.63 % | $ 1.47 B | NYSE,SPB | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.17 | -5.65 % | $ 47.6 M | Nasdaq Global Select Market | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | USA |
 |
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | USA |
 |
STRATA Skin Sciences
SSKN
|
- | - | $ 6.6 M | Nasdaq Global Select Market | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
AVITA Medical
RCEL
|
$ 3.82 | -1.04 % | $ 106 M | Nasdaq Global Select Market |  Australia |
 |
AxoGen
AXGN
|
$ 31.28 | -3.01 % | $ 1.44 B | Nasdaq Capital Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.